Free Trial

Pasithea Therapeutics (KTTAW) Competitors

$0.03 +0.01 (+42.50%)
As of 03/11/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

KTTAW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Pasithea Therapeutics stock or one of its competitors? The main competitors of Pasithea Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Pasithea Therapeutics vs.

Pasithea Therapeutics (NASDAQ:KTTAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Pasithea Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Pasithea TherapeuticsN/AN/A
180 Life SciencesN/AN/A

In the previous week, Pasithea Therapeutics and Pasithea Therapeutics both had 1 articles in the media. Pasithea Therapeutics' average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that Pasithea Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Pasithea Therapeutics Very Positive
180 Life Sciences Very Positive

Company Net Margins Return on Equity Return on Assets
Pasithea TherapeuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pasithea Therapeutics$486.56KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Pasithea Therapeutics beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Remove Ads
Get Pasithea Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KTTAW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KTTAW vs. The Competition

MetricPasithea TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$114.77M$5.67B$8.01B
Dividend YieldN/A3.69%4.89%4.03%
P/E RatioN/A3.2223.8318.90
Price / SalesN/A4,252.28378.33118.45
Price / CashN/A13.0138.0534.62
Price / BookN/A36.026.844.18
Net IncomeN/A-$87.82M$3.19B$246.59M
7 Day PerformanceN/A-1.28%-2.49%-3.40%
1 Month PerformanceN/A-2.39%-7.51%-9.30%
1 Year PerformanceN/A95.80%8.62%0.65%

Pasithea Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KTTAW
Pasithea Therapeutics
N/A$0.03
+42.5%
N/A+106.5%$0.00$486,559.000.003Positive News
ATNFW
180 Life Sciences
N/A$0.01
+3.0%
N/A+21.4%$0.00N/A0.007Positive News
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AARD
Aardvark Therapeutics
N/A$12.00
-5.7%
N/AN/A$0.00N/A0.0018Analyst Forecast
Analyst Revision
News Coverage
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+17.0%
N/A-85.4%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.08
-12.0%
N/A+73.4%$0.00$40,633.000.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$2.05
-6.8%
N/A-64.5%$0.00$391.87M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
-2.9%
N/AN/A$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.08
+36.4%
N/A+45.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.08
-22.7%
N/AN/A$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.10
-5.0%
N/A-93.6%$0.00N/A0.008Positive News
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:KTTAW) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners